Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VDT vs VDTC in untreated multiple myeloma
NCT00531453Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00531453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531453.